Biodexa Pharmaceticals Ownership

Stocks . USA . 
Stock . Biodexa Pharmaceticals
BDRX Stock   4.27  0.57  11.78%   
Biodexa Pharmaceticals shows 8.82 percent of its outstanding shares held by insiders and 29.85 percent owned by other corporate entities.
Some institutional investors establish a significant position in stocks such as Biodexa Pharmaceticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biodexa Pharmaceticals, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodexa Pharmaceticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.

Biodexa Stock Ownership Analysis

About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biodexa Pharmaceticals recorded a loss per share of 74.69. The entity last dividend was issued on the 3rd of March 2020. The firm had 1:25 split on the 4th of October 2024. For more info on Biodexa Pharmaceticals please contact Stephen Stamp at 44 29 2048 0180 or go to https://www.biodexapharma.com.

Biodexa Pharmaceticals Corporate Filings

6K
13th of February 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
28th of January 2025
Other Reports
ViewVerify
13A
20th of November 2024
An amended filing to the original Schedule 13G
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CSXCSX Corporation
ETONEton Pharmaceuticals
ALLTAllot Communications

Additional Tools for Biodexa Stock Analysis

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY